The induced sputum allows guide a therapeutic strategy to control bronchial asthma
DOI:
https://doi.org/10.31053/1853.0605.v67.n4.22577Keywords:
asthma control, induced sputum, strategy guided by induced putumAbstract
In spite of physiopathogenic and therapeutic advances, asthma remains uncontrolled.
The purpose of this test is to assess whether the instruments commonly used in the management of asthma are sufficient tools to control asthma, comparing the information provided by clinical evidence with cellular inflammatory parameters obtained through the analysis of induced sputum.
We studied 15 asthmatics under treatment, which were evaluated the asthma control status (ACS) by clinical and spirometrical criteria, according to GINA recommendations. Then each patient underwent to obtain a sample of induced sputum (IE) and it was further analysed as a previously validated tech nique. From the total number of patients, 7 were total controlled patients according to ACS; only 2 of them had a normal IE cellular pattern while the other 5 presented an inflammatory profile in the differential cells count of the IE, forced to make adjustments in the anti-inflammatory treatment. One partially controlled patient by ACS, revealed inflammatory parameters in IE allowing modify the therapeutic schema. In 7 not controlled patients by ACS, the cellular inflammatory characteristics in IE, allowed modify therapeutic strategy which achieved control of the disease.
We concluded that inflamommetry by IE cellular analysis is the tool that contributes to optimize the treatment and achieve true control of the disease.We suggest including this procedure in clinical practice and proposing a strategy for the management of asthma.
Downloads
References
Rabe KF, Vermeire PA, Soriano, JB And Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000 16: 802–807.
GINA (Global Initiative for Asthma). 2007 Global Strategy for Asthma Management and prevention. Available from http://www.ginasthma.org.
NAEPP (National Asthma Education and Prevention Program) (2007) Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and management of Asthma – Full Report. Available from http://www.nhlbi.nih.gov
Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004 113(1): 59–65.
Schatz M, Sorkness CA, Li JT, Marcus P, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immuno. 2006 117(3): 549–556.
Brusasco, R. Crapo and G. Viegi. ‘‘ATS/ERS task force: standardisation of lung function testing’’. Eur Respir J 2005; 26: 319–338
Uribe Echevarría E, Pérez P, Bonaterra M, et al. Safety, reproducibility and validity of induced sputum technique. Archivos de Alergia e Inmunologia Clinica. 2003; 34: 41-46.
Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid phase measurements. Am J Respir Crit Care Med. 1996;154:308-317.
Ciba Guest Symposium. Terminology, definitions and classifications of chronic pulmonary emphysema and related conditions. Thorax 1959;14,286-299.
American Thoracic Society, Medical Section of the National Tuberculosis Association. Chronic bronchitis, asthma, and pulmonary emphysema: a statement by the Committee on Diagnostic Standards for Non-tuberculous Respiratory Diseases. Am Rev Respir Dis. 1962;85,762-768.
Moritz P, Steidle LJ, Felisbino MB, et al. Determination of the inflammatory component of airway diseases by induced sputum cell counts: use in clinical practice. J Bras Pneumol. 2008;34(11):913-921.
National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma - Summary Report 2007. J Allergy Clin Immunol. 2007; 120: Suppl. 5, S94–S138.
Revicki D,Weiss KB. Clinical assessment of asthma symptom control: review of current assessment instruments. J Asthma. 2006; 43: 481–487.
Yawn BP, Brenneman SK, Allen-Ramey FC, et al. Assessment of asthma severity and asthma control in childre. Pediatrics. 2006; 118: 322–329.
Juniper EF, Bousquet J, Abetz L, Bateman ED, GOAL Committee. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2006; 100: 616–621.
Cazzola, M. Asthma control: evidence-based monitoring and the prevention of exacerbations. Breathe. 2008; 4: 310-319.
Wong HH, Fahy JV. Safety of one method of sputum induction in asthmatic subjects. Am J Respir Crit Care Med. 1997;156(1):299-303.
Fortuna AM, Feixas T, González M, Casan P. Diagnostic utility of inflammatory biomarkers in asthma: exhaled nitric oxide and induced sputum eosinophil count. Respir Med. 2007;101(11):2416-21.
Pavord ID, Sterk PJ, Hargreave FE, et al. Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl.. 2002;37:S40-S3.
Ulińska D, Szmidt M. Usefulness of the eosinophil count in induced sputum of asthmatic patients. Pneumonol Alergol Pol. 2001;69(9-10):581-589.
Vlachos-Mayer H, Leigh R, Sharon RF, et al. Success and safety of sputum induction in the clinical setting. Eur Respir. J 2000;16(5):997-1000.
Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med.
;163:1693-1722.
Barnes PJ and Woolcock AJ. Difficult asthma. Eur Respir. J 1998; 12:1209-1218.
Jayaram L, Parameswaran K, Sears MR, and Hargreave FE. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir. J 2000; 16: 150-158.
Downloads
Published
How to Cite
Issue
Section
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
